000220.KS

Yuyu Pharma, Inc. [000220.KS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

000220.KS Stock Summary

Top 10 Correlated ETFs

000220.KS


Top 10 Correlated Stocks

000220.KS


In the News

000220.KS Financial details

Company Rating
Buy
Market Cap
81.67B
Income
-7.54B
Revenue
137.34B
Book val./share
-
Cash/share
-
Dividend
105
Dividend %
2.06%
Employees
344
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
-11.06
Forward P/E
-
PEG
-0.16
P/S
0.61
P/B
0.74
P/C
-
P/FCF
-4.96
Quick Ratio
-
Current Ratio
1.99
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-466.34
EPS next Y
-
EPS next Q
-
EPS this Y
362.81%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
10.82%
Revenue Q/Q
-0.37%
EPS Q/Q
-23.38%
-
-
-
-
SMA20
16.17%
SMA50
6.08%
SMA100
0.98%
Inst Own
-
Inst Trans
-
ROA
-4%
ROE
-7%
ROC
-
Gross Margin
37%
Oper. Margin
-
Profit Margin
-5%
Payout
-
Shs Outstand
16.35M
Shs Float
10.54M
-
-
-
-
Target Price
-
52W Range
4160.0-6880.0
52W High
-26.31%
52W Low
+21.88%
RSI
56.49
Rel Volume
1.12
Avg Volume
364.08K
Volume
408.03K
Perf Week
-0.39%
Perf Month
15.23%
Perf Quarter
-9.14%
Perf Half Y
-12.89%
-
-
-
-
Beta
0.614
-
-
Volatility
190.11%, 332.95%
Prev Close
-3.24%
Price
5070
Change
3.15%

000220.KS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
6.6K7.27K7.9K7.25K8.38K
Net income per share
319.5378194.34-57.67-266.9
Operating cash flow per share
485.581.06K-215282.51-375.68
Free cash flow per share
-314.68356.11-1.37K-140.5-711.47
Cash per share
2.19K1.93K1.65K3.15K1.86K
Book value per share
6.82K7.1K9.21K7.79K7.05K
Tangible book value per share
6.77K7.09K9.12K7.8K7.22K
Share holders equity per share
6.82K7.1K9.21K7.79K7.05K
Interest debt per share
2.25K2.3K1.75K2.59K2.52K
Market cap
64.49B70.9B90.62B124.64B103.13B
Enterprise value
64.73B70.99B90.25B113.54B116.57B
P/E ratio
16.0415.0137.56-135.44-23.3
Price to sales ratio
0.780.780.921.080.74
POCF ratio
10.555.38-33.9527.64-16.56
PFCF ratio
-16.2915.94-5.34-55.59-8.74
P/B Ratio
0.750.80.7910.88
PTB ratio
0.750.80.7910.88
EV to sales
0.780.780.920.980.84
Enterprise value over EBITDA
7.886.449.6815.8720.38
EV to operating cash flow
10.595.38-33.8125.18-18.71
EV to free cash flow
-16.3515.96-5.32-50.64-9.88
Earnings yield
0.060.070.03-0.01-0.04
Free cash flow yield
-0.060.06-0.19-0.02-0.11
Debt to equity
0.320.30.170.320.34
Debt to assets
0.20.20.130.20.2
Net debt to EBITDA
0.030.01-0.04-1.552.35
Current ratio
2.481.533.53.291.5
Interest coverage
4.754.523.571.220.27
Income quality
1.422.37-1.11-4.91.41
Dividend Yield
0.020.020.020.010.02
Payout ratio
0.340.310.63-2.01-0.46
Sales general and administrative to revenue
0.050.050.040.030.04
Research and developement to revenue
0.020.010.040.030.06
Intangibles to total assets
0.010.010.020.020.02
Capex to operating cash flow
-1.65-0.665.35-1.50.89
Capex to revenue
-0.12-0.1-0.15-0.06-0.04
Capex to depreciation
-4.73-2.8-3.66-1.5-1.11
Stock based compensation to revenue
00000
Graham number
7K7.77K6.35K3.18K6.5K
ROIC
0.040.060.030.040.01
Return on tangible assets
0.030.030.020-0.02
Graham Net
485.0595.62754.71987.2-130.02
Working capital
41.08B22.56B46.07B68.87B32.04B
Tangible asset value
85.17B88.57B113.2B124.55B119.66B
Net current asset value
20.52B17.88B26.6B34.59B24.53B
Invested capital
0.320.30.170.320.34
Average receivables
24.54B23.3B20.46B21.38B24.11B
Average payables
6.76B5.72B5.84B7.13B12.41B
Average inventory
17.6B16.32B20.35B24.46B32.53B
Days sales outstanding
112.0884.6673.8372.2966.52
Days payables outstanding
43.4752.6536.5146.6267.57
Days of inventory on hand
134.24140.3163.6130.93169.91
Receivables turnover
3.264.314.945.055.49
Payables turnover
8.46.93107.835.4
Inventory turnover
2.722.62.232.792.15
ROE
0.050.050.02-0.01-0.04
Capex per share
-800.26-699.32-1.15K-423.01-335.8

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
2.05K2.1K2.07K2.16K0
Net income per share
-99.46-108.9327.63-2180
Operating cash flow per share
-160.58-128.86-51.34-349.960
Free cash flow per share
-194.4-255.3-131.86-451.180
Cash per share
2.17K1.86K1.65K1.65K0
Book value per share
7.05K7.05K6.86K7.3K0
Tangible book value per share
7.14K7.22K7.04K7.49K0
Share holders equity per share
7.05K7.05K6.86K7.3K0
Interest debt per share
2.43K2.35K2.58K2.94K0
Market cap
94.75B103.13B98.16B79.97B0
Enterprise value
98.2B116.57B114.5B100.88B0
P/E ratio
-14.3-14.2753.56-5.780
Price to sales ratio
2.782.972.862.340
POCF ratio
-35.43-48.27-115.31-14.40
PFCF ratio
-29.27-24.36-44.9-11.170
P/B Ratio
0.810.880.860.690
PTB ratio
0.810.880.860.690
EV to sales
2.883.363.342.950
Enterprise value over EBITDA
166.5295.858.29152.680
EV to operating cash flow
-36.72-54.56-134.51-18.170
EV to free cash flow
-30.33-27.54-52.37-14.090
Earnings yield
-0.02-0.020-0.040
Free cash flow yield
-0.03-0.04-0.02-0.090
Debt to equity
0.340.340.360.40
Debt to assets
0.210.20.210.230
Net debt to EBITDA
5.8411.051.1831.640
Current ratio
1.651.51.452.031.99
Interest coverage
-0.720.41.09-0.420
Income quality
1.611.18-1.861.750
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.040.040.350.030.37
Research and developement to revenue
0.060.080.080.080
Intangibles to total assets
0.020.020.020.020
Capex to operating cash flow
0.210.981.570.290
Capex to revenue
-0.02-0.06-0.04-0.050
Capex to depreciation
-0.44-1.6-1.03-1.110
Stock based compensation to revenue
00000
Graham number
3.97K4.16K2.07K5.98K0
ROIC
000.010-0.01
Return on tangible assets
-0.01-0.010-0.02-0.01
Graham Net
285.46-130.02-449.41-524.440
Working capital
37.24B32.04B30.24B50.79B46.82B
Tangible asset value
118.86B119.66B116.66B118.89B120.8B
Net current asset value
27.81B24.53B21.67B22.76B18.31B
Invested capital
0.340.340.360.40
Average receivables
25.63B25.69B24.99B24.72B12.38B
Average payables
10.73B13.32B15.97B14.96B6.9B
Average inventory
30.53B36.04B42.46B47.05B24.5B
Days sales outstanding
68.7165.5764.7565.130
Days payables outstanding
43.7967.7470.7957.320
Days of inventory on hand
130.72170.34198.18203.490
Receivables turnover
1.311.371.391.380
Payables turnover
2.061.331.271.570
Inventory turnover
0.690.530.450.440
ROE
-0.01-0.020-0.03-0.02
Capex per share
-33.81-126.45-80.52-101.220

000220.KS Frequently Asked Questions

What is Yuyu Pharma, Inc. stock symbol ?

Yuyu Pharma, Inc. is a KR stock and trading under the symbol 000220.KS

What is Yuyu Pharma, Inc. stock quote today ?

Yuyu Pharma, Inc. stock price is $5070 today.

Is Yuyu Pharma, Inc. stock public?

Yes, Yuyu Pharma, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs